213 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Rank Status Study
1 Not yet recruiting MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
Conditions: Psoriasis;   Plaque Type Psoriasis;   Moderate to Severe Plaque Psoriasis
Interventions: Drug: MSB11022;   Drug: Humira®
2 Recruiting Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
Conditions: Chronic Plaque Psoriasis;   Psoriasis
Interventions: Biological: M923;   Biological: Humira
3 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
4 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
5 Recruiting Diabetes and Psoriasis
Conditions: Diabetes;   Psoriasis
Intervention: Other: PASI and HOMA index
6 Recruiting A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Apremilast
7 Recruiting Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: GSK2981278 0.03%;   Drug: GSK2981278 0.1%;   Drug: GSK2981278 0.8%;   Drug: GSK2981278 4%;   Drug: Vehicle;   Drug: Betamethasone valerate 0.1%
8 Recruiting A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: CP-690,550
9 Unknown  miRNAs and mRNAs in Psoriasis
Condition: Psoriasis
Intervention: Other: 4 mm punch biopsies
10 Unknown  Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
Conditions: Tuberculosis;   Psoriasis
Intervention: Other: Tuberculin skin test and Quantiferon -TB Gold test
11 Not yet recruiting The Association Between Psoriasis and Intestinal Bacterial Population
Condition: Psoriasis
Intervention:
12 Recruiting A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
Condition: Psoriasis
Interventions: Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab
13 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
14 Recruiting Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index, as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis
Condition: Psoriasis
Intervention: Drug: Secukinumab
15 Recruiting BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis
Condition: Psoriasis
Intervention: Other: Withdrawal of venous blood samples
16 Recruiting Comparative Analysis of Small and Large Plaque Psoriasis
Condition: Psoriasis
Intervention: Procedure: Skin biopsy and blood test
17 Recruiting Excimer Laser, Serum Markers & Psoriasis
Condition: Psoriasis
Intervention: Device: Excimer laser treatment
18 Not yet recruiting Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
Condition: Psoriasis
Interventions: Other: Acetylcholine iontophoresis;   Other: Sodium Nitroprussiate iontophoresis;   Other: ppi water iontophoresis;   Other: Laser Doppler recording
19 Recruiting Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
Condition: Psoriasis
Intervention:
20 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years